NR
Neena Rasaily
About Neena Rasaily
Data last updated:
Neena Rasaily is a Director at Rebrace Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Rebrace Pharmaceuticals Private Limited reported revenue of ₹7.71 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rebrace Pharmaceuticals Private Limited U51909WB2020PTC238994 | Director | 18 Aug 2020 | 2020 | ₹7.71 Cr (FY 2024) | Active |
Board colleagues of Neena Rasaily
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kabita Baruah Medhi | 09035509 | Rebrace Pharmaceuticals Private Limited | Director |
| Rohit Swarnakar | 08467960 | Rebrace Pharmaceuticals Private Limited | Director |
| Sourami Saha | 10163532 | Rebrace Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neena Rasaily
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neena Rasaily
Neena Rasaily currently holds 1 directorship: Rebrace Pharmaceuticals Private Limited (Director, since 18 Aug 2020, revenue ₹7.71 Cr (FY 2024)).
Neena Rasaily was first appointed on 18 Aug 2020 as Director at Rebrace Pharmaceuticals Private Limited.
The current boards of Neena Rasaily's companies include Kabita Baruah Medhi (Rebrace Pharmaceuticals Private Limited), Rohit Swarnakar (Rebrace Pharmaceuticals Private Limited), Sourami Saha (Rebrace Pharmaceuticals Private Limited).